Publication | Closed Access

Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer’s disease therapy

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeuropharmacologyPharmacotherapyNeurologyNeuroprotectionLeading CandidatePharmacologyInhibitory ActivityDrug Discovery